Bill

Bill > A05029


NY A05029

NY A05029
Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.


summary

Introduced
02/11/2025
In Committee
01/07/2026
Crossed Over
Passed
Dead

Introduced Session

2025-2026 General Assembly

Bill Summary

AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine autoinjectors for dispensation by pharmacists

AI Summary

This bill amends the New York education law to allow pharmacists to substitute a brand name epinephrine auto-injector with an alternate epinephrine auto-injector under specific conditions. The pharmacist can make this substitution if: the prescriber has not specified that the prescription must be dispensed exactly as written, the alternate auto-injector is available at a lower cost to the patient, the pharmacist has advised the patient or their representative about the alternate option and received their consent, and the pharmacist has provided counseling on how to properly use the alternate device. An epinephrine auto-injector is a medical device used to quickly deliver a dose of epinephrine (adrenaline) during a severe allergic reaction, with the most well-known brand being EpiPen. The bill aims to provide patients with more affordable options for this critical medical device while ensuring patient safety through informed consent and professional guidance. The law would take effect immediately upon passage.

Committee Categories

Education

Sponsors (1)

Last Action

referred to higher education (on 01/07/2026)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...